v3.26.3
STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT - USD ($)
Common stock
Class A Ordinary Shares
Common stock
Class B Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Class B Ordinary Shares
Total
Beginning balance at May. 10, 2026 $ 0 $ 0 [1] $ 0 $ 0   $ 0
Beginning balance (in shares) at May. 10, 2026 0 0        
Increase (Decrease) in Stockholders' Equity            
Issuance of Class B ordinary shares [1]   $ 503 24,497     25,000
Issuance of Class B ordinary shares (in shares) [1]   5,031,250        
Net Income (Loss)       (53,327)   (53,327)
Ending balance at Jun. 30, 2026 $ 0 $ 503 [1] 24,497 (53,327)   (28,327)
Ending balance (in shares) at Jun. 30, 2026 0 5,031,250        
Beginning balance at May. 10, 2026 $ 0 $ 0 [1] 0 0   0
Beginning balance (in shares) at May. 10, 2026 0 0        
Increase (Decrease) in Stockholders' Equity            
Net Income (Loss)           1,446,983
Ending balance at Sep. 30, 2026   $ 503 [1]   (7,394,476)   (7,393,973)
Ending balance (in shares) at Sep. 30, 2026   5,031,250     5,031,250  
Beginning balance at Jun. 30, 2026 $ 0 $ 503 [1] 24,497 (53,327)   (28,327)
Beginning balance (in shares) at Jun. 30, 2026 0 5,031,250        
Increase (Decrease) in Stockholders' Equity            
Sale of Private Placement Warrants     5,500,000     5,500,000
Fair value of Warrants included in Public units     5,272,750     5,272,750
Allocated value of transaction costs to Public and Private Placement Warrants     (345,128)     (345,128)
Accretion of Class A ordinary shares subject to redemption upon initial measurement     $ (10,452,119) (7,102,523)   (17,554,642)
Subsequent accretion of Class A ordinary shares subject to redemption to redemption amount       (1,738,936)   (1,738,936)
Net Income (Loss)       1,500,310   1,500,310
Ending balance at Sep. 30, 2026   $ 503 [1]   $ (7,394,476)   $ (7,393,973)
Ending balance (in shares) at Sep. 30, 2026   5,031,250     5,031,250  
[1] Includes an aggregate of up to 656,250 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 5). On July 6, 2026, the underwriter exercised its over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 656,250 Founder Shares are no longer subject to forfeiture.